DE602005017423D1 - Thiazolopyridinon-derivate als mch-rezeptorantagonisten - Google Patents
Thiazolopyridinon-derivate als mch-rezeptorantagonistenInfo
- Publication number
- DE602005017423D1 DE602005017423D1 DE602005017423T DE602005017423T DE602005017423D1 DE 602005017423 D1 DE602005017423 D1 DE 602005017423D1 DE 602005017423 T DE602005017423 T DE 602005017423T DE 602005017423 T DE602005017423 T DE 602005017423T DE 602005017423 D1 DE602005017423 D1 DE 602005017423D1
- Authority
- DE
- Germany
- Prior art keywords
- thiazolopyridinone
- derivatives
- receptor antagonists
- mch receptor
- amelioration
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US63714304P | 2004-12-17 | 2004-12-17 | |
PCT/US2005/045866 WO2006066174A1 (en) | 2004-12-17 | 2005-12-16 | Thiazolopyridinone derivates as mch receptor antagonists |
Publications (1)
Publication Number | Publication Date |
---|---|
DE602005017423D1 true DE602005017423D1 (de) | 2009-12-10 |
Family
ID=36123161
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE602005017423T Active DE602005017423D1 (de) | 2004-12-17 | 2005-12-16 | Thiazolopyridinon-derivate als mch-rezeptorantagonisten |
Country Status (12)
Country | Link |
---|---|
US (1) | US7902356B2 (de) |
EP (1) | EP1828207B1 (de) |
JP (1) | JP5072602B2 (de) |
CN (1) | CN101080411B (de) |
AT (1) | ATE446962T1 (de) |
AU (1) | AU2005316314B2 (de) |
BR (1) | BRPI0519124A2 (de) |
CA (1) | CA2589695A1 (de) |
DE (1) | DE602005017423D1 (de) |
ES (1) | ES2333243T3 (de) |
MX (1) | MX2007007227A (de) |
WO (1) | WO2006066174A1 (de) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1798221A4 (de) | 2004-10-01 | 2010-04-07 | Banyu Pharma Co Ltd | Stickstoffhaltige heterocyclische 2-arylcarbonsäureamidverbindung |
US8455658B2 (en) | 2006-01-25 | 2013-06-04 | Synta Pharmaceuticals Corp. | Thiazole and thiadiazole compounds for inflammation and immune-related uses |
JP5198439B2 (ja) * | 2006-06-08 | 2013-05-15 | イーライ リリー アンド カンパニー | 新規なmch受容体アンタゴニスト |
EP2089397B1 (de) * | 2006-12-14 | 2012-08-29 | Eli Lilly & Company | 5-[4-(azetidin-3-yloxy)-phenyl]-2-phenyl-5h-thiazolo-[5,4-c]pyridin-4-on-derivate und ihre verwendung als mch-rezeptor-antagonisten |
WO2008140239A1 (en) * | 2007-05-11 | 2008-11-20 | Korea Research Institute Of Chemical Technology | Imidazole derivatives having aryl piperidine substituent, method for preparation thereof and pharmaceutical compositions containing same |
DE102007028925A1 (de) | 2007-06-22 | 2008-12-24 | Saltigo Gmbh | Verfahren zur Herstellung von 2-Phenoxyacetalen und den daraus korrespondierenden 2-Phenoxycarbaldehyden |
US20090076275A1 (en) * | 2007-09-19 | 2009-03-19 | David Robert Bolin | Diacylglycerol acyltransferase inhibitors |
JPWO2010024258A1 (ja) | 2008-08-29 | 2012-01-26 | 塩野義製薬株式会社 | Pi3k阻害活性を有する縮環アゾール誘導体 |
EP2513118B1 (de) | 2009-12-18 | 2013-09-18 | Janssen Pharmaceutica, N.V. | Bicyclische Thiazole als allosterische Modulatoren der mGluR5-Rezeptoren |
BR112012014436A2 (pt) | 2009-12-18 | 2019-09-24 | Janssen Pharmaceutica Nv | tiazóis bicíclicos como moduladores alostéricos de receptores mglur5 |
KR101893751B1 (ko) | 2010-07-16 | 2018-09-03 | 애브비 아일랜드 언리미티드 컴퍼니 | 항바이러스성 화합물의 제조 방법 |
US8975443B2 (en) | 2010-07-16 | 2015-03-10 | Abbvie Inc. | Phosphine ligands for catalytic reactions |
US9255074B2 (en) | 2010-07-16 | 2016-02-09 | Abbvie Inc. | Process for preparing antiviral compounds |
BR112013001138A2 (pt) | 2010-07-16 | 2016-07-05 | Abbvie Inc | ligantes de fosfina para reações catalíticas |
CN102532123B (zh) * | 2010-12-29 | 2016-03-09 | 中国医学科学院药物研究所 | 噻唑-5-甲酰胺化合物、及其制法和药物组合物与用途 |
WO2012109573A1 (en) * | 2011-02-11 | 2012-08-16 | Purdue Research Foundation | Substituted thiazoles for use as antiviral agents |
JP6185979B2 (ja) * | 2012-03-27 | 2017-08-23 | バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングBayer Intellectual Property GmbH | 除草活性及び殺虫活性を有するチアゾロピリジノン類 |
WO2013168759A1 (ja) | 2012-05-10 | 2013-11-14 | 武田薬品工業株式会社 | 芳香環化合物 |
TR201815683T4 (tr) | 2014-01-13 | 2018-11-21 | Aurigene Discovery Tech Ltd | Irak4 inhibitörleri olarak bisiklik heterosiklil türevleri. |
WO2015138280A2 (en) * | 2014-03-10 | 2015-09-17 | Innov17 Llc | Retinoic acid receptor-related orphan receptor modulators and uses thereof |
US20150252022A1 (en) * | 2014-03-10 | 2015-09-10 | Innov17 Llc | Retinoic acid receptor-related orphan receptor modulators and uses thereof |
KR20180025896A (ko) * | 2015-07-15 | 2018-03-09 | 오리진 디스커버리 테크놀로지스 리미티드 | Irak-4 저해제로서 인다졸 및 아자인다졸 화합물 |
KR102646115B1 (ko) * | 2016-03-11 | 2024-03-12 | 에이씨 이뮨 에스에이 | 진단 및 치료를 위한 바이사이클릭 화합물 |
SI3600270T1 (sl) | 2017-03-31 | 2023-10-30 | Aurigene Oncology Limited | Spojine in sestavki za zdravljenje hematoloških motenj |
EP3704108B1 (de) | 2017-10-31 | 2024-04-24 | Curis, Inc. | Irak4-inhibitor in kombination mit einem bcl-2-inhibitor zur verwendung bei der behandlung von krebs |
CN109928939A (zh) * | 2019-02-27 | 2019-06-25 | 上海卡洛化学有限公司 | 一种2,2,6,6-四甲基吗啉的制备方法 |
EP4320127A1 (de) | 2021-04-05 | 2024-02-14 | Halia Therapeutics, Inc. | Nek7-inhibitoren |
WO2022226182A1 (en) | 2021-04-22 | 2022-10-27 | Halia Therapeutics, Inc. | Nek7 inhibitors |
CN115403456B (zh) * | 2022-09-22 | 2023-11-17 | 成都大学 | 一种合成爱德万甜中间体3-羟基-4-甲氧基苯丙醛的方法 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0867678A (ja) * | 1993-11-10 | 1996-03-12 | Takeda Chem Ind Ltd | 複素環アミド化合物、その製造法および剤 |
JP2002371059A (ja) * | 2000-05-16 | 2002-12-26 | Takeda Chem Ind Ltd | メラニン凝集ホルモン拮抗剤 |
US7229986B2 (en) * | 2000-05-16 | 2007-06-12 | Takeda Pharmaceutical Company Ltd. | Melanin-concentrating hormone antagonist |
GB0124627D0 (en) | 2001-10-15 | 2001-12-05 | Smithkline Beecham Plc | Novel compounds |
SE0202134D0 (sv) * | 2002-07-08 | 2002-07-08 | Astrazeneca Ab | Therapeutic agents |
WO2004052848A1 (en) | 2002-12-11 | 2004-06-24 | Eli Lilly And Company | Novel mch receptor antagonists |
US20040214856A1 (en) * | 2003-04-23 | 2004-10-28 | Pfizer Inc | Cannabinoid receptor ligands and uses thereof |
WO2005047293A1 (en) | 2003-11-07 | 2005-05-26 | Neurocrine Biosciences, Inc. | Melanin-concentrating hormone receptor antagonists and compositions and methods related thereto |
MX2007007226A (es) * | 2004-12-17 | 2007-08-21 | Lilly Co Eli | Antagonistas receptores novedosos de hormona concentradora de melanina (mch). |
EP1987020B1 (de) | 2006-02-15 | 2012-10-03 | Sanofi | Azacyclylsubstituierte aryldihydroisochinolinone, verfahren zu ihrer herstellung und ihre verwendung als medikamente |
-
2005
- 2005-12-16 AU AU2005316314A patent/AU2005316314B2/en not_active Ceased
- 2005-12-16 JP JP2007546991A patent/JP5072602B2/ja not_active Expired - Fee Related
- 2005-12-16 BR BRPI0519124-6A patent/BRPI0519124A2/pt not_active IP Right Cessation
- 2005-12-16 CN CN2005800431124A patent/CN101080411B/zh not_active Expired - Fee Related
- 2005-12-16 MX MX2007007227A patent/MX2007007227A/es active IP Right Grant
- 2005-12-16 DE DE602005017423T patent/DE602005017423D1/de active Active
- 2005-12-16 US US11/721,079 patent/US7902356B2/en not_active Expired - Fee Related
- 2005-12-16 CA CA002589695A patent/CA2589695A1/en not_active Abandoned
- 2005-12-16 EP EP05854554A patent/EP1828207B1/de not_active Not-in-force
- 2005-12-16 AT AT05854554T patent/ATE446962T1/de not_active IP Right Cessation
- 2005-12-16 ES ES05854554T patent/ES2333243T3/es active Active
- 2005-12-16 WO PCT/US2005/045866 patent/WO2006066174A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
BRPI0519124A2 (pt) | 2008-12-23 |
MX2007007227A (es) | 2007-08-21 |
US20090233919A1 (en) | 2009-09-17 |
CA2589695A1 (en) | 2006-06-22 |
EP1828207B1 (de) | 2009-10-28 |
CN101080411A (zh) | 2007-11-28 |
US7902356B2 (en) | 2011-03-08 |
JP2008524250A (ja) | 2008-07-10 |
AU2005316314A1 (en) | 2006-06-22 |
ES2333243T3 (es) | 2010-02-18 |
CN101080411B (zh) | 2011-11-02 |
JP5072602B2 (ja) | 2012-11-14 |
EP1828207A1 (de) | 2007-09-05 |
WO2006066174A1 (en) | 2006-06-22 |
AU2005316314B2 (en) | 2011-06-23 |
ATE446962T1 (de) | 2009-11-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE446962T1 (de) | Thiazolopyridinon-derivate als mch- rezeptorantagonisten | |
DK1828177T3 (da) | Hidtil ukendte MCH-receptorantagonister | |
WO2007146758A3 (en) | Novel mch receptor antagonists | |
DK1735278T3 (da) | Histamin H3-receptormidler, fremstilling og terapeutiske anvendelser | |
NO20064065L (no) | Diaminopyrimidiner som P2X3 og P2X2/3 antagonister | |
MA28432B1 (fr) | Antagonistes du recepteur de la chimiokine | |
TW200800946A (en) | Substituted piperazines as metabotropic glutamate receptor antagonists | |
ATE466842T1 (de) | 3-substituierte pyridinderivate als h3- antagonisten | |
EA200970341A1 (ru) | Пиразолиновые соединения в качестве антагонистов минералокортикоидных рецепторов | |
DE602005023197D1 (de) | -muscarinrezeptors | |
MX2009004900A (es) | Arilamidas sustituidas por tiazol u oxazol. | |
ATE399770T1 (de) | Tachykininrezeptorantagonisten | |
TW200800943A (en) | Indane derivatives as MCH receptor antagonists | |
MX2010006230A (es) | Derivados de arilamida substituidos con triazol y su uso como antagonistas de receptor purinergico p2x3 y/o p2x2/3. | |
DE602005022572D1 (de) | Antagonisten des opioidrezeptors | |
ATE475645T1 (de) | Pyrrolidinderivate als doppelte nk1/nk3- rezeptorenantagonisten | |
ATE418548T1 (de) | Substituierte 3-cyanothiophen acetamide als glucagon receptor antagonisten | |
CY1109694T1 (el) | Παραγωγα πυρρολιδινης ως ανταγωνιστες υποδοχεα η3 ισταμινης | |
ATE496918T1 (de) | Als a2b-adenosinrezeptorantagonisten geeignete 5- phenyl-6-pyridin-4-yl-1,3-dihydro-2h-imidazoä4, - büpyridin-2-onderivate | |
WO2005040157A3 (en) | Novel mch receptor antagonists | |
ATE399164T1 (de) | Antagonisten des opioidrezeptors | |
TW200700067A (en) | Substituted aryl 1,4-pyrazine derivatives | |
MX2008001607A (es) | Piperazinas biciclicas como antagonistas del receptor de glutamato metabotropico. | |
EA200970189A1 (ru) | Пирролидинонанилины как модуляторы прогестероновых рецепторов | |
EA015500B9 (ru) | Новые антагонисты мсн рецепторов |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8328 | Change in the person/name/address of the agent |
Representative=s name: DR. SCHOEN & PARTNER, 80336 MUENCHEN |